Description de l'entreprise
Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership.
Conseil d'administration & Conseil de surveillance
PDG |
Thomas Meier |
Conseil d'administration |
Alain Schaffter, Dr. Günther Loidl, Torsten Wohr |
Conseil de surveillance |
Dr. Kuno Sommer, Nicole Grogg Hötzer, Dr. Alex Fässler, Dr. Steffen Lang, Prof. Dr. Helma Wennemers, Dr. h.c. Peter Grogg |
Données de l'entreprise
Nom: |
Bachem Holding AG |
Adresse: |
Hauptstraße 144,CH-4416 Bubendorf |
Téléphone: |
+41-58-595-2020 |
Fax: |
+41-58-595-2040 |
Courriel: |
sales.ch@bachem.com
|
Internet: |
www.bachem.com |
Industrie: |
Healthcare |
Secteur: |
Pharmaceutical Industry |
Sous-secteur: |
Pharmaceuticals |
Fin de l'exercice financier: |
31/12 |
Flotte libre: |
38.00% |
IPO date: |
22/07/1998 |
Relations avec les investisseurs
Nom: |
Daniel Grotzky |
Téléphone IR: |
+41-58-595-2021 |
IR-Fax: |
+41-58-595-2043 |
E-mail IR: |
ir@bachem.com
|